Total investments

126

Average round size

41M

Portfolio companies

115

Rounds per year

1.37

Lead investments

21

Follow on index

0.09

Exits

69

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyHealth CareHealth DiagnosticsManufacturingMedical DeviceMedicalTelecommunications

Summary

In 1932 was created GE Capital, which is appeared as VC. The company was established in North America in Canada. GE Capital appeared to be a CVC structure as part of the corporation. The main department of described VC is located in the Ottawa.

The overall number of key employees were 4.

The top amount of exits for fund were in 2003. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2000. Deals in the range of 10 - 50 millions dollars are the general things for fund. This GE Capital works on 22 percentage points more the average amount of lead investments comparing to the other organizations. The typical startup value when the investment from GE Capital is 100-500 millions dollars.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the GE Capital, startups are often financed by Kleiner Perkins, Intel Capital, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Intel Capital, Kleiner Perkins, Pappas Ventures. In the next rounds fund is usually obtained by OrbiMed, Walden International, Prolog Ventures.

We can highlight the next thriving fund investment areas, such as Biotechnology, E-Commerce. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline NetScreen Technologies, View, CardioDx

Show more

Investments analytics

Analytics

Total investments
126
Lead investments
21
Exits
69
Rounds per year
1.37
Follow on index
0.09
Investments by industry
  • Health Care (40)
  • Biotechnology (27)
  • Medical Device (24)
  • Internet (20)
  • Software (16)
  • Show 122 more
Investments by region
  • United States (106)
  • United Kingdom (6)
  • Brazil (2)
  • India (2)
  • Israel (3)
  • Show 4 more
Peak activity year
2000
Number of Unicorns
3
Number of Decacorns
3
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
26
Avg. valuation at time of investment
150M
Group Appearance index
0.70
Avg. company exit year
17
Avg. multiplicator
1.07
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Asera 21 Dec 1999 Internet, B2B, Business Intelligence Early Stage Venture 47M United States, California, Redwood City
Check 27 Aug 2020 Seed 100K
eVoice 01 Jan 2000 Small and Medium Businesses, Cloud Computing, Telecommunications, Email Marketing Seed 0 United States, California, Los Angeles
Prescient Markets 11 Aug 2000 Internet, Financial Services, Marketing, Electronics Early Stage Venture 15M United States, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.